Market Tracker

04/21 10:39am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

123.02
BATS BZX Real-Time Price
As of 10:36am ET
 +4.34 / +3.66%
Today’s Change
47.03
Today|||52-Week Range
132.99
+26.82%
Year-to-Date

Today’s Trading

Previous close118.68
Today’s open130.02
Day’s range119.01 - 132.99
Volume695,555
Average volume (3 months)757,117
Market cap$10.0B
Dividend yield--
Data as of 10:23am ET, 04/21/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.62%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book9.79

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.20+0.30%
ISISIsis Pharmaceuticals...+1.81+2.78%
ICLRICON PLC+0.72+1.03%
DYAXDyax Corp+0.18+0.64%
Data as of 10:38am ET, 04/21/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts